Cargando…

ADAM8 Is an Antigen of Tyrosine Kinase Inhibitor-Resistant Chronic Myeloid Leukemia Cells Identified by Patient-Derived Induced Pluripotent Stem Cells

Properties of cancer stem cells involved in drug resistance and relapse have significant effects on clinical outcome. Although tyrosine kinase inhibitors (TKIs) have dramatically improved survival of patients with chronic myeloid leukemia (CML), TKIs have not fully cured CML due to TKI-resistant CML...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miyauchi, Masashi, Koya, Junji, Arai, Shunya, Yamazaki, Sho, Honda, Akira, Kataoka, Keisuke, Yoshimi, Akihide, Taoka, Kazuki, Kumano, Keiki, Kurokawa, Mineo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5919294/ https://www.ncbi.nlm.nih.gov/pubmed/29429960 http://dx.doi.org/10.1016/j.stemcr.2018.01.015

Ejemplares similares

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate
por: Taoka, Kazuki, et al.
Publicado: (2018)

CAMK2G is identified as a novel therapeutic target for myelofibrosis
por: Miyauchi, Masashi, et al.
Publicado: (2022)

Evi1 is essential for hematopoietic stem cell self-renewal, and its expression marks hematopoietic cells with long-term multilineage repopulating activity
por: Kataoka, Keisuke, et al.
Publicado: (2011)

Cyclosporine Therapy in Patients with Transfusion-independent Non-severe Aplastic Anemia: A Retrospective Analysis
por: Matsuda, Kensuke, et al.
Publicado: (2018)

Evi1 forms a bridge between the epigenetic machinery and signaling pathways
por: Yoshimi, Akihide, et al.
Publicado: (2011)

Evi1 defines leukemia-initiating capacity and tyrosine kinase inhibitor resistance in chronic myeloid leukemia
por: Sato, T, et al.
Publicado: (2014)

The Development of Acute Systemic Multiple Thrombosis after Achieving Remission during Systemic Glucocorticoid Therapy for Acquired Hemophilia A
por: Toyama, Kazuhiro, et al.
Publicado: (2018)

Prognostic factors of Erdheim–Chester disease: a nationwide survey in Japan
por: Toya, Takashi, et al.
Publicado: (2018)

Treatment of Secondary Immune Thrombocytopenia with Non-Hodgkin Lymphoma: A Case Report and Literature Review
por: Kurihara, Yuya, et al.
Publicado: (2021)

Evi1 upregulates Fbp1 and supports progression of acute myeloid leukemia through pentose phosphate pathway activation
por: Mizuno, Hideaki, et al.
Publicado: (2021)

DNMT3A R882 mutants interact with polycomb proteins to block haematopoietic stem and leukaemic cell differentiation
por: Koya, Junji, et al.
Publicado: (2016)

Clinical application of genomic aberrations in adult T-cell leukemia/lymphoma
por: Kataoka, Keisuke, et al.
Publicado: (2020)

Expansion of large granular lymphocytes after autologous hematopoietic stem cell transplantation
por: Yoshida, Mina, et al.
Publicado: (2023)

Bing-Neel Syndrome Successfully Treated with Tirabrutinib
por: Oyama, Takashi, et al.
Publicado: (2022)

Inhibition of histone methyltransferase EZH2 depletes leukemia stem cell of mixed lineage leukemia fusion leukemia through upregulation of p16
por: Ueda, Koki, et al.
Publicado: (2014)

Multiple mutations within individual oncogenes
por: Saito, Yuki, et al.
Publicado: (2021)

Comparison of temporal changes in psychological distress after hematopoietic stem cell transplantation among the underlying diseases of Japanese adult patients
por: Fukuo, Wataru, et al.
Publicado: (2008)

Precise characterization of somatic complex structural variations from tumor/control paired long-read sequencing data with nanomonsv
por: Shiraishi, Yuichi, et al.
Publicado: (2023)

Intracellular signals of lung cancer cells as possible therapeutic targets
por: Tanaka, Kiyomichi, et al.
Publicado: (2015)

Clinical Features and Prognostic Factors for Primary Anaplastic Large Cell Lymphoma of the Central Nervous System: A Systematic Review
por: Hirano, Yudai, et al.
Publicado: (2021)

Impact of vitamin D level at diagnosis and transplantation on the prognosis of hematological malignancy: a meta-analysis
por: Ito, Yusuke, et al.
Publicado: (2022)

COVID-19 mRNA Vaccine in Patients With Lymphoid Malignancy or Anti-CD20 Antibody Therapy: A Systematic Review and Meta-Analysis
por: Ito, Yusuke, et al.
Publicado: (2022)

HIV Activates the Tyrosine Kinase Hck to Secrete ADAM Protease-Containing Extracellular Vesicles
por: Lee, J.-H., et al.
Publicado: (2018)

Tyrosine Hydroxylase (TH)- and Aromatic-L-Amino Acid Decarboxylase (AADC)-Immunoreactive Neurons of the Common Marmoset (Callithrix jacchus) Brain: An Immunohistochemical Analysis
por: Karasawa, Nobuyuki, et al.
Publicado: (2007)

Aberrant RNA splicing and therapeutic opportunities in cancers
por: Yamauchi, Hirofumi, et al.
Publicado: (2021)

Author Correction: Cellular basis of omentum activation and expansion revealed by single-cell RNA sequencing using a parabiosis model
por: Ishigaki, Kazuhiko, et al.
Publicado: (2021)

Cellular basis of omentum activation and expansion revealed by single-cell RNA sequencing using a parabiosis model
por: Ishigaki, Kazuhiko, et al.
Publicado: (2021)

The First Case of Concomitant Mycobacterium Genavense Lymphadenitis and EBV-Positive Lymphoproliferative Disorder
por: Ito, Yusuke, et al.
Publicado: (2020)

Myeloid sarcoma and pathological fracture: a case report and review of literature
por: Takeyasu, Sho, et al.
Publicado: (2023)

Hair-Follicle-Associated Pluripotent (HAP) Stem Cells Can Extensively Differentiate to Tyrosine-Hydroxylase-Expressing Dopamine-Secreting Neurons
por: Yamane, Michiko, et al.
Publicado: (2021)

ADAM12 and ADAM17 are essential molecules for hypoxia-induced impairment of neural vascular barrier function
por: Cui, Dan, et al.
Publicado: (2015)

Adam
Publicado: (1880)

LGI1 and LGI4 bind to ADAM22, ADAM23 and ADAM11
por: Sagane, Koji, et al.
Publicado: (2008)

Induction of CYP3A activity by dexamethasone may not be strong, even at high doses: insights from a case of tacrolimus co-administration
por: Ohno, Yoshiyuki, et al.
Publicado: (2023)

Amlodipine versus angiotensin II receptor blocker; control of blood pressure evaluation trial in diabetics (ADVANCED-J)
por: Kawamori, Ryuzo, et al.
Publicado: (2006)

Real-World Outcome Analysis of Patients With Stage IV NSCLC Treated With Tyrosine Kinase and Immune Checkpoint Inhibitors
por: Ariyasu, Ryo, et al.
Publicado: (2023)

ADAM and EVA
Publicado: (1970)

Adam Kraft.
por: Schwemmer, Wilhelm
Publicado: (1958)

Nick Adams
por: Hemingway, Ernest, 1899-1961
Publicado: (1974)

Adam Blake
por: Garci, José Luis
Publicado: (1972)

Cannot write session to /tmp/vufind_sessions/sess_cmduik4ioa6ocf00697tthhm29